AI could help pick surgery or ablation for liver cancer patients
NCT ID NCT07582419
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test whether an artificial intelligence (AI) model can help doctors decide between surgery and microwave ablation for people with early-stage liver cancer. The AI will analyze images from contrast-enhanced ultrasound and MRI scans to predict the risk of cancer returning within two years. Over 1,400 participants will be followed to see if the AI's recommendation leads to better outcomes. The goal is to make treatment decisions more personalized and reduce recurrence rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- artificial intelligence (AI) model analyzing contrast-enhanced ultrasound and MRI images
- What this could lead to
- If successful, this AI tool could help doctors personalize treatment for early-stage liver cancer, potentially lowering the chance of cancer coming back within two years.
- What could go wrong
- This is an early-stage observational study, not a treatment trial. The AI model may not work as well in real-world settings or for all patients, and it does not test a new drug or therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Hospital of jilin University
Changchun, Jilin, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 'No-Touch' microwave technique match surgery for liver tumors?
- Can blood tests reveal how liver and bile duct cancers respond to treatment?
- AI-Powered surveillance may outsmart liver cancer recurrence
- Blood markers may forecast liver cancer treatment success
- Can a diabetes drug help fight liver cancer? a trial puts it to the test
- Can a triple therapy shrink untreatable liver tumors?